HealthDay on MSN5h
Heart Failure Patients With Ejection Fraction Improvement Rarely Withdrawn From MedsIn patients with heart failure with improved ejection fraction (EF), pharmacological therapy is rarely withdrawn, according ...
BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the year ended ...
BACKGROUND: Morbidity and mortality of heart failure with preserved ejection fraction (HFpEF) is increased in metabolic disorders. However, options for preventing and treating these prevalent outcomes ...
Bayer announced today that data from 13 new analyses from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the American College of Cardiology (ACC) 74th ...
Compared with those who spent most of their time in a single room, people with heart failure with preserved ejection fraction ...
There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...
“People with heart failure with mildly reduced or preserved ejection fraction face substantial challenges in diagnosis, treatment and follow-up care,” said Robert Perkins, MD, MPH ...
News-Medical.Net on MSN1d
Increased mobility linked to lower risk of hospitalization in heart failure patientsCompared with those who spent most of their time in a single room, people with heart failure with preserved ejection fraction (HFpEF) who were able to travel outside of their home without assistance ...
A 76-year-old woman presents with a persistently rapid heart rate that she attributes to her pacemaker. What does the ECG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback